Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 16 to 30 of 34 results for metformin

  1. Fertility problems: assessment and treatment (CG156)

    This guideline covers diagnosing and treating fertility problems. It aims to reduce variation in practice and improve the way fertility problems are investigated and managed.

    Clinical guideline
    Last updated
    6 September 2017
    View recommendations

    Sections for CG156

  2. Type 2 diabetes: insulin degludec/liraglutide (Xultophy) (ESNM60)

    Summary of the evidence on insulin degludec/liraglutide (Xultophy) for treating type 2 diabetes to inform local NHS planning and decision-making

    Evidence summary
    Published
    3 July 2015

  3. Non-metformin-based drug treatment combinations to control blood glucose levels: In adults with type 2 diabetes, what treatment combinations (for example, glucagon‑like peptide‑1 [GLP‑1] mimetics and insulin combination therapy with meglitinides) are most effective when initial drug treatment with non‑metformin monotherapy fails to adequately control blood glucose levels?

    Recommendation ID NG28/02 Question Non-metformin-based drug treatment combinations to control blood glucose levels: In adults with type

    Research recommendation
    Published
    16 December 2021

  4. Metreleptin for treating lipodystrophy (HST14)

    Evidence-based recommendations on metreleptin (Myalepta) for treating lipodystrophy in children and adults.

    Highly specialised technologies guidance
    Published
    24 February 2021
    View recommendations

    Sections for HST14

  5. Abdominal aortic aneurysm: diagnosis and management (NG156)

    This guideline covers diagnosing and managing abdominal aortic aneurysms. It aims to improve care by helping people who are at risk to get tested, specifying how often to monitor asymptomatic aneurysms, and identifying when aneurysm repair is needed and which procedure will work best.

    NICE guideline
    Published
    19 March 2020
    View recommendations

    Sections for NG156

  6. Endoscopic duodenal mucosal resurfacing for insulin resistance in type 2 diabetes (IPG787)

    Evidence-based recommendations on endoscopic duodenal mucosal resurfacing for insulin resistance in type 2 diabetes. This involves using heat to destroy the lining of the duodenum to encourage a new lining to grow.

    Interventional procedures guidance
    Published
    16 May 2024
    View recommendations

    Sections for IPG787

  7. Vitamin B12 deficiency in over 16s: diagnosis and management (NG239)

    This guideline covers recognising, diagnosing and managing vitamin B12 deficiency in people aged 16 and over, including deficiency caused by autoimmune gastritis. It also covers monitoring for gastric cancer in people with autoimmune gastritis.

    NICE guideline
    Published
    6 March 2024
    View recommendations

    Sections for NG239

  8. Brain tumours (primary) and brain metastases in over 16s (NG99)

    This guideline covers diagnosing, monitoring and managing any type of primary brain tumour or brain metastases in people aged 16 or over. It aims to improve diagnosis and care, including standardising the care people have, how information and support are provided, and palliative care.

    NICE guideline
    Last updated
    29 January 2021
    View recommendations

    Sections for NG99

  9. The effect of drug therapy for concurrent conditions on melanoma survival: In people diagnosed with melanoma what is the effect of drug therapy to treat concurrent conditions on disease specific survival? This should be investigated in a national prospective cohort study. Secondary outcomes should include overall survival and quality of life.

    effects that may affect survival in people with melanoma. For example, metformin, the most frequently prescribed drug for type 2...

    Research recommendation
    Published
    4 August 2022

  10. Type 2 diabetes in adults (QS209)

    This quality standard covers prevention of type 2 diabetes in adults (aged 18 and over) and care and treatment for adults with type 2 diabetes. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    2 March 2023
    View quality statements

    Sections for QS209

  11. A Medicines Optimisation Service

    medication that was causing Q-T prolongation and risk of lactic acidosis with metformin in renal impairment. Patients and staff were...

    Shared learning
    Last updated
    2 July 2018

  12. Are there effective long-term pharmacological interventions to prevent the onset of type 2 diabetes that can be recommended postnatally for women who have been diagnosed with gestational diabetes?

    some data suggesting that changes in diet and exercise, with or without metformin, can prevent type 2 diabetes developing in...

    Research recommendation
    Published
    9 June 2015

  13. Reducing incidence of Urinary Tract Infections by promoting hydration in care homes

    education about dehydration, AKI, UTIs, Diuretics, ACE inhibitors/ARBs, Metformin and NSAIDs (DAMN medicines, antimicrobial resistance...

    Shared learning
    Last updated
    27 June 2018

  14. Type 1 diabetes in adults: diagnosis and management (NG17)

    This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.

    NICE guideline
    Last updated
    17 August 2022
    View recommendations

    Sections for NG17

  15. Diabetes in children and young people (QS125)

    This quality standard covers diagnosing and managing type 1 and type 2 diabetes in children and young people (under 18). It describes high-quality care in priority areas for improvement.

    Quality standard
    Last updated
    31 March 2022
    View quality statements

    Sections for QS125